Can transcutaneous bilirubinometry safely be used to monitor rebound hyperbilirubinaemia after phototherapy in neonates ≥35 weeks' gestation? A prospective, comparative study.

Frances Rose ButterworthRichard BoultonShona CampbellGillian FrewHelen Mactier

Published in: Archives of disease in childhood. Fetal and neonatal edition (2024)

35 weeks' gestation but adopting a wide safety margin has potential to reduce blood sampling. Recommencement of phototherapy is uncommon in this population.

Keyphrases

gestational age
preterm birth
preterm infants
low birth weight
human health
risk assessment